scispace - formally typeset
J

Jaana Rich

Researcher at Helsinki University of Technology

Publications -  29
Citations -  570

Jaana Rich is an academic researcher from Helsinki University of Technology. The author has contributed to research in topics: Bioactive glass & Polymer. The author has an hindex of 13, co-authored 29 publications receiving 542 citations. Previous affiliations of Jaana Rich include Aalto University.

Papers
More filters
Journal ArticleDOI

In vitro evaluation of poly(ε-caprolactone-co-DL-lactide)/bioactive glass composites

TL;DR: In vitro bioactivity of composites of poly(e-caprolactone-co-DL-lactide) P(CL/DL-LA) containing different amounts (40, 60 and 70 W%) of bioactive glass, S53P4, was evaluated as mentioned in this paper.
Journal ArticleDOI

In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(ε-caprolactone-co-dl-lactide) and bioactive glass (S53P4)

TL;DR: The results indicate that composites containing over 40 wt% BAG granules are bioactive, and that a higher BAG surface area/volume ratio favors the apatite formation in vitro.
Journal ArticleDOI

Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: Concept and experimental outcome with thermoplastic composites of poly(epsilon-caprolactone-co-D,L-lactide) and bioactive glass S53P4

TL;DR: Injectable composites of particulate bioactive glass S53P4 (BAG) and Poly(ε-caprolactone-co-D,L-lactide) as thermoplastic carrier matrix investigated as bone fillers in cancellous and cartilagineous subchondral bone defects in rabbits indicate a suitable working concept as a filler bone substitute for sub chondral cancellous bone defects.
Journal ArticleDOI

Modification of dextran using click-chemistry approach in aqueous media

TL;DR: In this article, dextran was modified using click-chemistry, including the introduction of azide functionalities to the backbone of the polysaccharide using base-catalysis in water/isopropanol mixture at ambient temperature.
Journal ArticleDOI

An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis

TL;DR: In vitro bone filling composite materials that release ciprofloxacin to kill any remaining bacteria and contain bioceramic to help the bone to heal showed great potential to be developed into bone filler materials for the treatment of osteomyelitis or other bone related infections.